Health Resources International Ltd

Health Resources International Limited was established in 2003 in the United Kingdom. The company was originally set up to supply UK organizations (both public and private) with hospital consultants and specialists from Eastern Europe. We have dealt with consultants, junior doctors and general practitioners (primary care physicians), supplying them on a fixed, short term, sessional, rotational or locum basis. Since incorporation we have recruited a couple of hundreds of medical professionals in the UK, the majority of which have been consultants in permanent positions.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CAMENA BIOSCIENCE HITS DNA SYNTHESIS MILESTONE

Labiotech | February 06, 2020

news image

Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being placed on DNA sequencing and manipulation tools....

Read More

MEDICAL

TEXAS CHILDREN'S PAVILION FOR WOMEN ACQUIRES AUSTIN PERINATAL ASSOCIATES EXPANDING HOSPITAL'S MATERNAL-FETAL MEDICINE FOOTPRINT TO CENTRAL TEX

Texas Children's Hospital | May 09, 2022

news image

Texas Children's Physician Group announced today that it has completed the acquisition of Austin Perinatal Associates, a well-known private maternal-fetal medicine practice based in Austin. Located at 6500 North Mopac Expressway, the facility is the ninth community maternal-fetal medicine clinic operated by the Texas Children's Pavilion for Women and the first to offer women's services in Central Texas – bringing the hospital's well-known, top tier women'...

Read More

CELL AND GENE THERAPY

PERKINELMER COMPLETES ACQUISITION OF ANTIBODY AND REAGENT LEADER BIOLEGEND

PerkinElmer | September 18, 2021

news image

PerkinElmer, Inc.a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the Company’s life science franchise into high-growth areas such as cytometry, proteogenomics, multiplex assays, recombinant protei...

Read More

DIVERSE BIOTECH ANNOUNCES ORPHAN-DRUG DESIGNATION FOR TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA

Diverse Biotech | May 04, 2020

news image

Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request for one of its investigational new therapies for treatment of newly diagnosed glioblastoma, in conjunction with standard treatment, following adjuvant combined chemo-radiation. Orphan designation qualifies the sponsor of the drug for various development incentives of the ODA, (Orphan Drug Act) including tax credits for qualified clinical te...

Read More
news image

CAMENA BIOSCIENCE HITS DNA SYNTHESIS MILESTONE

Labiotech | February 06, 2020

Camena Bioscience has achieved a significant DNA synthesis milestone by reproducing the DNA sequence of a whole plasmid, which could be used in synthetic biology applications such as protein production and bacterial engineering. DNA synthesis is a field that, until recently, had not been a focus for companies developing innovative technologies, with greater importance being placed on DNA sequencing and manipulation tools....

Read More
news image

MEDICAL

TEXAS CHILDREN'S PAVILION FOR WOMEN ACQUIRES AUSTIN PERINATAL ASSOCIATES EXPANDING HOSPITAL'S MATERNAL-FETAL MEDICINE FOOTPRINT TO CENTRAL TEX

Texas Children's Hospital | May 09, 2022

Texas Children's Physician Group announced today that it has completed the acquisition of Austin Perinatal Associates, a well-known private maternal-fetal medicine practice based in Austin. Located at 6500 North Mopac Expressway, the facility is the ninth community maternal-fetal medicine clinic operated by the Texas Children's Pavilion for Women and the first to offer women's services in Central Texas – bringing the hospital's well-known, top tier women'...

Read More
news image

CELL AND GENE THERAPY

PERKINELMER COMPLETES ACQUISITION OF ANTIBODY AND REAGENT LEADER BIOLEGEND

PerkinElmer | September 18, 2021

PerkinElmer, Inc.a global leader committed to innovating for a healthier world, today announced it has completed its acquisition of BioLegend, a leading, worldwide provider of life science antibodies and reagents for a total consideration of approximately $5.25 billion. The acquisition, the largest in PerkinElmer’s history, further expands the Company’s life science franchise into high-growth areas such as cytometry, proteogenomics, multiplex assays, recombinant protei...

Read More
news image

DIVERSE BIOTECH ANNOUNCES ORPHAN-DRUG DESIGNATION FOR TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA

Diverse Biotech | May 04, 2020

Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request for one of its investigational new therapies for treatment of newly diagnosed glioblastoma, in conjunction with standard treatment, following adjuvant combined chemo-radiation. Orphan designation qualifies the sponsor of the drug for various development incentives of the ODA, (Orphan Drug Act) including tax credits for qualified clinical te...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us